Litcius/Paper detail

Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer

Wenyan She, Haimei Li, Zichen Wang, Tingting Liu, Dongli Zhao, Zhibin Guo, Yujiao Liu, Yi Liu

2024Journal of Controlled Release31 citationsDOI

Topics & Concepts

Triple-negative breast cancerTumor microenvironmentCancer researchChemistryCancer cellTumor hypoxiaImmunotherapyCitric acid cycleImmune systemCancerBreast cancerBiologyBiochemistryMedicineImmunologyRadiation therapyMetabolismInternal medicineTumor cellsNanoplatforms for cancer theranosticsImmune cells in cancerCancer, Hypoxia, and Metabolism
Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer | Litcius